Literature DB >> 21828976

Growing prevalence of vancomycin-resistant Enterococcus faecalis in the region with the highest prevalence of vancomycin-resistant Staphylococcus aureus.

Kayoko Hayakawa1, Dror Marchaim, Celine Vidaillac, Paul Lephart, Jason M Pogue, Bharath Sunkara, Harikrishna Kotra, Asma Hasan, Maryann Shango, Yashwanth Yerramalla, Adedayo M Osunlana, Teena Chopra, Sorabh Dhar, Hossein Salimnia, Michael J Rybak, Keith S Kaye.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21828976     DOI： 10.1086/661599

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


× No keyword cloud information.
  9 in total

1.  Predictors of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci co-colonization among nursing facility patients.

Authors:  Kevin Heinze; Mohammed Kabeto; Emily Toth Martin; Marco Cassone; Liam Hicks; Lona Mody
Journal:  Am J Infect Control       Date:  2018-11-28       Impact factor: 2.918

2.  β-Lactams enhance daptomycin activity against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium in in vitro pharmacokinetic/pharmacodynamic models.

Authors:  Jordan R Smith; Katie E Barber; Animesh Raut; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2015-03-09       Impact factor: 5.191

3.  Impact of different antimicrobial therapies on clinical and fiscal outcomes of patients with bacteremia due to vancomycin-resistant enterococci.

Authors:  Kayoko Hayakawa; Emily T Martin; Uma Mahesh Gudur; Dror Marchaim; Dalia Dalle; Khaled Alshabani; Kalyan Srinivas Muppavarapu; Fnu Jaydev; Pradeep Bathina; Pranathi Rao Sundaragiri; Shashi Dhar Rajuri; Jaikumar Khatri; Jason M Pogue; Paul R Lephart; Michael J Rybak; Keith S Kaye
Journal:  Antimicrob Agents Chemother       Date:  2014-05-05       Impact factor: 5.191

4.  Comparison of the clinical characteristics and outcomes associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant E. faecium bacteremia.

Authors:  Kayoko Hayakawa; Dror Marchaim; Emily T Martin; Namita Tiwari; Adnan Yousuf; Bharath Sunkara; Harish Pulluru; Harikrishna Kotra; Asma Hasan; Suchitha Bheemreddy; Puja Sheth; Dae-Won Lee; Srinivasa Kamatam; Pradeep Bathina; Priyanka Nanjireddy; Indu K Chalana; Satyam Patel; Sarwan Kumar; Amit Vahia; Kimberly Ku; Victoria Yee; Jessie Swan; Jason M Pogue; Paul R Lephart; Michael J Rybak; Keith S Kaye
Journal:  Antimicrob Agents Chemother       Date:  2012-02-21       Impact factor: 5.191

5.  β-Lactam combinations with daptomycin provide synergy against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium.

Authors:  Jordan R Smith; Katie E Barber; Animesh Raut; Mostafa Aboutaleb; George Sakoulas; Michael J Rybak
Journal:  J Antimicrob Chemother       Date:  2015-02-01       Impact factor: 5.790

6.  Epidemiology of vancomycin-resistant Enterococcus faecalis: a case-case-control study.

Authors:  Kayoko Hayakawa; Dror Marchaim; Mohan Palla; Uma Mahesh Gudur; Harish Pulluru; Pradeep Bathina; Khaled Alshabani; Aditya Govindavarjhulla; Ashwini Mallad; Deepika Reddy Abbadi; Deepti Chowdary; Hari Kakarlapudi; Harish Guddati; Manoj Das; Naveen Kannekanti; Praveen Vemuri; Rajiv Doddamani; Venkat Ram Rakesh Mundra; Raviteja Reddy Guddeti; Rohan Policherla; Sarika Bai; Sharan Lohithaswa; Shiva Prasad Shashidharan; Sowmya Chidurala; Sreelatha Diviti; Krishna Sukayogula; Melwin Joseph; Jason M Pogue; Paul R Lephart; Emily T Martin; Michael J Rybak; Keith S Kaye
Journal:  Antimicrob Agents Chemother       Date:  2012-10-15       Impact factor: 5.191

7.  Independent risk factors for the co-colonization of vancomycin-resistant Enterococcus faecalis and methicillin-resistant Staphylococcus aureus in the region most endemic for vancomycin-resistant Staphylococcus aureus isolation.

Authors:  K Hayakawa; D Marchaim; P Bathina; E T Martin; J M Pogue; B Sunkara; S Kamatam; K Ho; L B Willis; M Ajamoughli; D Patel; A Khan; K P Lee; U Suhrawardy; K K Jagadeesh; S M L Reddy; M Levine; F Ahmed; A M Omotola; M Mustapha; J A Moshos; M J Rybak; K S Kaye
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-01-26       Impact factor: 3.267

8.  Safety of topical vancomycin powder in neurosurgery.

Authors:  Kalil G Abdullah; H Isaac Chen; Timothy H Lucas
Journal:  Surg Neurol Int       Date:  2016-12-05

9.  Detection of β-Lactamase-Producing Enterococcus faecalis and Vancomycin-Resistant Enterococcus faecium Isolates in Human Invasive Infections in the Public Hospital of Tandil, Argentina.

Authors:  Celia M Schell; Ana P Tedim; Mercedes Rodríguez-Baños; Mónica D Sparo; Sabina Lissarrague; Juan A Basualdo; Teresa M Coque
Journal:  Pathogens       Date:  2020-02-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.